Measuring Myocardial Energetics with Cardiovascular Magnetic Resonance Spectroscopy.

The heart has the highest energy demands per gram of any organ in the body and energy metabolism fuels normal contractile function. Metabolic inflexibility and impairment of myocardial energetics occur with several common cardiac diseases, including ischemia and heart failure. This review explores several decades of innovation in cardiac magnetic resonance spectroscopy modalities and their use to noninvasively identify and quantify metabolic derangements in the normal, failing, and diseased heart. The implications of this noninvasive modality for predicting significant clinical outcomes and guiding future investigation and therapies to improve patient care are discussed.

• Publication year

  2021

• Venue

  Heart Failure Clinics

• Publication date

  2021-01-01

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1016/j.hfc.2020.08.011PMID 33220883
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Measuring inorganic phosphate and intracellular pH in the healthy and hypertrophic cardiomyopathy hearts by in vivo 7T 31P-cardiovascular magnetic resonance spectroscopy

  2019cited by this paper
• Cardiac work is related to creatine kinase energy supply in human heart failure: a cardiovascular magnetic resonance spectroscopy study

  2018cited by this paper
• Creatine kinase rate constant in the human heart measured with 3D‐localization at 7 tesla

  2016cited by this paper
• Two repetition time saturation transfer (TwiST) with spill-over correction to measure creatine kinase reaction rates in human hearts

  2015cited by this paper
• Reproducibility of creatine kinase reaction kinetics in human heart: a 31P time‐dependent saturation transfer spectroscopy study

  2014cited by this paper
• Quantification of human high‐energy phosphate metabolite concentrations at 3 T with partial volume and sensitivity corrections

  2013cited by this paper
• Creatine kinase adenosine triphosphate and phosphocreatine energy supply in a single kindred of patients with hypertrophic cardiomyopathy.

  2013cited by this paper
• Metabolic Rates of ATP Transfer Through Creatine Kinase (CK Flux) Predict Clinical Heart Failure Events and Death

  2013cited by this paper
• Human cardiac 31P magnetic resonance spectroscopy at 7 tesla

  2013cited by this paper
• Clinical Implications of Cardiac Hyperpolarized Magnetic Resonance Imaging

  2013cited by this paper
• Effects of Catecholamine Stress on Diastolic Function and Myocardial Energetics in Obesity

  2012cited by this paper
• Allopurinol acutely increases adenosine triphospate energy delivery in failing human hearts.

  2012cited by this paper
• Hyperpolarized Magnetic Resonance: A Novel Technique for the In Vivo Assessment of Cardiovascular Disease

  2011cited by this paper
• Clinical features of myocardial triglyceride in different types of cardiomyopathy assessed by proton magnetic resonance spectroscopy: comparison with myocardial creatine.

  2010cited by this paper
• Relationship Between Coronary Microvascular Dysfunction and Cardiac Energetics Impairment in Type 1 Diabetes Mellitus

  2010cited by this paper
• Triple repetition time saturation transfer (TRiST) 31P spectroscopy for measuring human creatine kinase reaction kinetics

  2010cited by this paper
• Real‐time assessment of Krebs cycle metabolism using hyperpolarized C magnetic resonance spectroscopy

  2009cited by this paper
• Cardiac effects of MDMA on the metabolic profile determined with 1H‐magnetic resonance spectroscopy in the rat

  2009cited by this paper
• Reduced Myocardial Creatine Kinase Flux in Human Myocardial Infarction: An In Vivo Phosphorus Magnetic Resonance Spectroscopy Study

  2009cited by this paper
• Cardiac metabolism measured noninvasively by hyperpolarized 13C MRI

  2008cited by this paper
• Progressive caloric restriction induces dose-dependent changes in myocardial triglyceride content and diastolic function in healthy men.

  2008cited by this paper
• The failing heart--an engine out of fuel.

  2007cited by this paper
• Altered Creatine Kinase Adenosine Triphosphate Kinetics in Failing Hypertrophied Human Myocardium

  2006cited by this paper
• Cardiac system bioenergetics: metabolic basis of the Frank‐Starling law

  2006cited by this paper
• Determination of triglyceride in the human myocardium by magnetic resonance spectroscopy: reproducibility and sensitivity of the method.

  2005cited by this paper
• ATP flux through creatine kinase in the normal, stressed, and failing human heart.

  2005cited by this paper
• Myocardial substrate metabolism in the normal and failing heart.

  2005cited by this paper
• Myocardial creatine concentration in various nonischemic heart diseases assessed by 1H magnetic resonance spectroscopy.

  2005cited by this paper
• Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart

  2004cited by this paper
• Cardiac and skeletal muscle involvement in myotonic dystrophy type 2 (DM2): A quantitative 31P‐MRS and MRI study

  2004cited by this paper
• Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR

  2003cited by this paper
• Abnormal Cardiac and Skeletal Muscle Energy Metabolism in Patients With Type 2 Diabetes

  2003cited by this paper
• Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus.

  2003cited by this paper
• Noninvasive localized MR quantification of creatine kinase metabolites in normal and infarcted canine myocardium.

  2001cited by this paper
• MRI/MRS assessment of in vivo murine cardiac metabolism, morphology, and function at physiological heart rates.

  2000cited by this paper
• Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms.

  2000cited by this paper
• Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs: a compensatory role for the parallel loss of creatine.

  1999cited by this paper
• Concentrations of human cardiac phosphorus metabolites determined by SLOOP 31P NMR spectroscopy

  1999cited by this paper
• Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism.

  1999cited by this paper
• Influence of aging or left ventricular hypertrophy on the human heart: Contents of phosphorus metabolites measured by 31P MRS

  1998cited by this paper
• Non-invasive magnetic-resonance detection of creatine depletion in non-viable infarcted myocardium.

  1998cited by this paper
• Human myocardial ATP content and in vivo contractile function

  1998cited by this paper
• Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy.

  1997cited by this paper
• Creatine kinase system in failing and nonfailing human myocardium.

  1996cited by this paper
• Human cardiac high‐energy phosphate metabolite concentrations by 1D‐resolved NMR spectroscopy

  1996cited by this paper
• Quantitative measurements of cardiac phosphorus metabolites in coronary artery disease by 31P magnetic resonance spectroscopy.

  1995cited by this paper
• 31P nuclear magnetic resonance spectroscopic imaging of regions of remodeled myocardium in the infarcted rat heart.

  1995cited by this paper
• Detection of myocardial ischemia by 31P magnetic resonance spectroscopy during handgrip exercise.

  1994cited by this paper
• Cardiac metabolism in patients with dilated and hypertrophic cardio‐myopathy: Assessment with proton‐decoupled P‐31 MR spectroscopy

  1992cited by this paper
• High-energy phosphate metabolism of the myocardium in normal subjects and patients with various cardiomyopathies--the study using ECG gated MR spectroscopy with a localization technique.

  1992cited by this paper
• 31P Magnetic Resonance Spectroscopy in Dilated Cardiomyopathy and Coronary Artery Disease: Altered Cardiac High‐Energy Phosphate Metabolism in Heart Failure

  1992cited by this paper
• Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy.

  1991cited by this paper
• Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy.

  1991cited by this paper
• Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease.

  1990cited by this paper
• Phosphate metabolite imaging and concentration measurements in human heart by nuclear magnetic resonance

  1990cited by this paper
• The effect of dobutamine on myocardial performance and high-energy phosphate metabolism at different stages of heart failure in cardiomyopathic hamsters: a 31P MRS study.

  1989cited by this paper
• Assessment of myocardial salvage after ischemia and reperfusion using magnetic resonance imaging and spectroscopy.

  1989cited by this paper
• Very rapid lactate measurement in ischemic perfused hearts using 1H MRS continuous negative echo acquisition during steady‐state frequency selective excitation

  1988cited by this paper
• Quantitative studies of human cardiac metabolism by 31P rotating-frame NMR.

  1987cited by this paper
• Noninvasive study of high-energy phosphate metabolism in human heart by depth-resolved 31P NMR spectroscopy.

  1985cited by this paper
• Noninvasive detection and monitoring of regional myocardial ischemia in situ using depth-resolved 31P NMR spectroscopy.

  1985cited by this paper
• The creatine kinase system in normal and diseased human myocardium.

  1985cited by this paper
• Studies of acidosis in the ischaemic heart by phosphorus nuclear magnetic resonance.

  1979cited by this paper
• Phosphorus nuclear magnetic resonance studies of heart physiology

  1978cited by this paper
• Phosphorus nuclear magnetic resonance of perfused working rat hearts

  1977cited by this paper
• Myocardial metabolism in congestive heart failure.

  1951cited by this paper
• THE CHEMICAL NATURE OF HEART FAILURE

  1939cited by this paper

• Individually tailored spatial–spectral pulsed CEST MRI for ratiometric mapping of myocardial energetic species at 3T

  2023cites this paper
• New Insights in Early Detection of Anticancer Drug-Related Cardiotoxicity Using Perfusion and Metabolic Imaging

  2022cites this paper
• In Vivo Magnetic Resonance Spectroscopy Methods for Investigating Cardiac Metabolism

  2022cites this paper
• Comparison of single-voxel 1H-cardiovascular magnetic resonance spectroscopy techniques for in vivo measurement of myocardial creatine and triglycerides at 3T

  2021cites this paper